AA
NUS icon

Antipodean Advisors’s Nu Skin NUS Stock Holding History

Antipodean Advisors’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-293,000
Closed -$40.5M – 26
2013
Q4 		$40.5M Buy
+293,000
New +$34.5M 3.5% 10

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ESG
Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Antipodean Advisors's NUS Position: Q1 2014 in Review

Antipodean Advisors sold out of Nu Skin (NUS) in Q1 2014, closing a stake of 293,000 shares — an estimated $40.5M sold.

Antipodean Advisors first reported a position in NUS in Q4 2013 and held it in 1 quarter. The position peaked at $40.5M in Q4 2013. 289 funds tracked by Wall St. Rank hold NUS as of Q1 2014.

  • Antipodean Advisors reported no remaining Nu Skin position as of Q1 2014 after selling out during the quarter.
  • Antipodean Advisors sold 293,000 Nu Skin shares in Q1 2014, an estimated $40.5M.
  • Antipodean Advisors first reported a position in Nu Skin in Q4 2013 and held it in 1 quarter.
  • Antipodean Advisors's Nu Skin position peaked at $40.5M in Q4 2013.
  • 289 funds tracked by Wall St. Rank held Nu Skin as of Q1 2014.

Based on Antipodean Advisors's 13F filing for Q1 2014, filed 15 May 2014.